Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Anastrozole and cyproterone acetate treatment can help increase adult height in boys with testotoxicosis.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Piperonylic acid may help hair growth and treat hair loss.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

The two finasteride preparations are bioequivalent.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Annurca apple supplement safely increases hair growth and keratin in humans.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib was effective in treating both early and late onset alopecia areata.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

A new treatment for hair loss shows promise with fewer side effects.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.